A prominent British laboratory is forming a special partnership that would sidestep the drug industry to sell a potential vaccine against the coronavirus without profits or licensing fees in Britain and in low- and middle-income countries nyti.ms
@forbes.com5 years ago
Direct Payments In Coronavirus Stimulus Bill Are Well Targeted To Low- And Middle-Income Households
@abc.net.au5 years ago
How Jordan has become an outlier on COVID-19 in the Middle East
@forbes.com5 years ago
Mike Bloomberg Announces $40 Million Plan To Combat Coronavirus In Developing Countries
@theconversation.com5 years ago
Five ways collective intelligence can help beat coronavirus in developing countries
@forbes.com5 years ago
Trump’s Decision To Defund WHO: Throwing The Baby Out With The Bathwater
